Association of MGMT Promoter Methylation Status with Survival Outcomes in Patients with High-Risk Glioma Treated with Radiotherapy and Temozolomide: An Analysis from the NRG Oncology/RTOG 0424 Trial

Erica H. Bell, Peixin Zhang, Barbara J. Fisher, David R. Macdonald, Joseph P. McElroy, Glenn J. Lesser, Jessica Fleming, Arup R. Chakraborty, Ziyan Liu, Aline P. Becker, Denise Fabian, Kenneth D. Aldape, Lynn S. Ashby, Maria Werner-Wasik, Eleanor M. Walker, Jean Paul Bahary, Young Kwok, H. Michael Yu, Nadia N. Laack, Christopher J. SchultzHeidi J. Gray, H. Ian Robins, Minesh P. Mehta, Arnab Chakravarti

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Association of MGMT Promoter Methylation Status with Survival Outcomes in Patients with High-Risk Glioma Treated with Radiotherapy and Temozolomide: An Analysis from the NRG Oncology/RTOG 0424 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences